Clinical trials
Recruiting Lymphoproliferative Disorders trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
33 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2004 | 1 |
| 2009 | 2 |
| 2013 | 1 |
| 2015 | 2 |
| 2017 | 2 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 3 |
| 2021 | 2 |
| 2022 | 1 |
| 2023 | 6 |
| 2024 | 2 |
| 2025 | 5 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 33 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cancer Research UK | 5 |
| National Cancer Institute (NCI) | 5 |
| Azienda Ospedaliero-Universitaria di Parma | 2 |
| UNC Lineberger Comprehensive Cancer Center | 2 |
| AVM Biotechnology Inc | 1 |
| Baylor College of Medicine | 1 |
| Children's Oncology Group | 1 |
| Curis, Inc. | 1 |
| Dana-Farber Cancer Institute | 1 |
| Emory University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoproliferative Disorders | 33 |
| Neoplasms | 13 |
| Lymphoma | 11 |
| Neoplasms by Histologic Type | 10 |
| Immune System Diseases | 8 |
| Multiple Myeloma | 8 |
| Lymphoma, Non-Hodgkin | 7 |
| Immunoproliferative Disorders | 6 |
| Neoplasms by Site | 6 |
| Hematologic Neoplasms | 5 |
Trials
Showing 1 to 25 of 33. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.